✦ LIBER ✦
Chemoprevention of cancer of uterine cervix: A study on chemoprevention of Retinamide II from cervical precancerous lesions
✍ Scribed by Ruidi, Chen; Aihua, Ding; Peiyu, Bao; Zhongru, Guo; Huazao, Luo; Shifeng, Sun; Rui, Han; Shiping, Xu
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 42 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Dysplasia of the uterine cervix is a recognized precancerous condition. Because of the observed ability of retinoids to suppress various cell lines in vitro, a number of clinical studies have examined the effect these agents have on cervical dysplasia, with the object of developing a means of chemoprevention of cervical malignancies in women at risk. Three cervical cancer chemoprevention trials with Retinamide II (RII) have been conducted at the Cancer Institute,